trial

A Placebo-Controlled Study of Physiologic Effects of L-methylfolate in Schizophrenia Patients

NCTId NCT01091506
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 55 (actual)
Sponsored by Pamlab, Inc.
Primary completion 2014-03
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
55 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2010-03
Primary completion
2014-03
Eligibility
ALL · 18 Years · 68 Years

Interventions & indications

Drugs
L-methylfolate

Sponsors

Pamlab, Inc.Lead Sponsor
Massachusetts General HospitalCollaborator

Investigators

1
Joshua Roffman, MDPrincipal Investigator

Sites

1 total
Boston, United States

Facts & assertions

4 sourced
Enrollment
55
Phase
NA
Primary Completion Date
2014-03
Status
COMPLETED
relationships
The graph out of here
drug
L-methylfolate
drug
lead_sponsor
Pamlab, Inc.
company
collaborator
Massachusetts General Hospital
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Joshua Roffman, MD
person